HomeStock ScreenerTarsons Products

Tarsons Products Share Price | Tarsons Products Stock Screener

TARSONS Medical Equipment
Share Price NSE
₹312.75
▼ -3.80 (-1.20%)
2026-07-24 00:00:00
Share Price BSE
₹312.55
▼ -3.30 (-1.04%)
2026-07-24 00:00:00
As of July 24, 2026, the Tarsons Products share price (NSE: TARSONS) is ₹312.75 on NSE and ₹312.55 on BSE, down 1.20% from the previous close, with shares trading between ₹310.00 and ₹317.85, and a 52-week range of ₹166.46–₹375.05. Analyse TARSONS share price history and track historical price performance. Use the Tarsons Products stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Tarsons Products Market Cap ₹1,660.30 Cr.
TARSONS P/E Ratio (TTM) 104.37
Tarsons Products P/B Ratio 2.35
EPS (TTM) ₹2.69
Dividend Yield -
Debt to Equity 0.49
TARSONS 52 Week High ₹375.05
Tarsons Products 52 Week Low ₹166.46
Operating Margin 28.00%
Profit Margin 3.12%
TARSONS Revenue (TTM) ₹128.00
EBITDA ₹41.00
Net Income ₹4.00
Total Assets ₹1,186.00
Total Equity ₹635.00

Tarsons Products Share Price Chart

Screen Tarsons Products share price with an interactive chart. Analyse TARSONS price trends and volatility across different timeframes.

Tarsons Products Company Profile - Fundamental Screener

Screen Tarsons Products company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for TARSONS shares.
Sector Healthcare
Industry Medical Equipment
Sub-Sector Medical Equipment
Segment E
ISIN INE144Z01023

Tarsons Products Balance Sheet Screener

Screen TARSONS balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
Item 2026 2025 2024 2022 2021
Assets
Total Assets 1,186 1,080 972 544 296
Current Assets 266 243 235 245 113
Fixed Assets 859 536 336 189 120
Liabilities
Total Liabilities 0 0 0 0 0
Current Liabilities 287 274 146 20 10
Non-Current Liabilities 0 0 0 0 0
Shareholders' Equity
Total Equity 635 630 613 490 244
Share Capital 11 11 11 11 0
Reserves & Surplus 624 620 602 479 244

Tarsons Products Income Statement Screener - Profit & Revenue Analysis

Screen Tarsons Products income statement and profit fundamentals. Analyze TARSONS quarterly results, revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Tarsons Products share price evaluation.
Item 2026-Mar 2025-Mar 2025-Jun 2025-Sept 2025-Dec 2024-Mar 2024-Jun 2024-Sept 2024-Dec 2023-Dec 2022-Mar 2021-Mar 2021-Jun 2021-Sept 2021-Dec
Revenue 128 117 95 108 116 109 88 108 97 65 88 68 71 77 73
Expenses 87 76 67 75 78 76 66 74 66 39 41 33 32 38 38
EBITDA 41 41 28 33 39 34 22 34 31 26 47 36 39 40 36
Operating Profit % 28.00% 33.00% 27.00% 27.00% 28.00% 29.00% 22.00% 26.00% 31.00% 37.00% 52.00% 52.00% 53.00% 50.00% 47.00%
Depreciation 29 20 20 23 25 12 11 14 17 10 7 3 5 5 5
Interest 6 5 5 5 6 4 4 5 5 3 0 1 1 2 1
Profit Before Tax 6 16 3 6 8 17 6 15 8 14 39 32 33 34 29
Tax 2 5 1 2 3 7 2 5 3 4 10 8 9 9 7
Net Profit 4 10 2 3 5 10 4 10 5 10 30 24 25 25 22
EPS 0.79 1.92 0.34 0.62 0.95 1.94 0.75 1.93 0.99 1.87 5.69 4.59 4.88 4.89 4.14

Tarsons Products Cash Flow Screener - Liquidity Fundamentals

Screen TARSONS cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
Item 2025-March 2024-March 2022-March 2021-March
Operating Activities 114 103 84 68
Investing Activities -145 -285 -138 -64
Financing Activities 39 136 130 -27
Net Cash Flow 8 -47 75 -23

Tarsons Products Shareholding Pattern Screener

See Tarsons Products shareholding pattern with promoter, FII, and DII holdings. Check Tarsons Products promoter holding and ownership changes for TARSONS on TickJournal.
Item 2026-Mar 2025-Mar 2025-Jun 2025-Sept 2025-Dec 2024-Mar 2024-Jun 2024-Sept
Promoter Holding 47.30% 47.31% 47.31% 47.31% 47.30% 47.31% 47.31% 47.31%
FII Holding 0.87% 9.52% 9.14% 5.82% 2.47% 8.16% 7.95% 8.04%
DII Holding 0.19% 0.29% 0.04% 0.08% 0.00% 0.18% 0.12% 0.21%
Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 21.54% 15.30% 15.42% 17.14% 20.33% 13.44% 13.53% 13.06%
Other Holding 30.10% 27.58% 28.09% 29.65% 29.89% 30.92% 31.10% 31.39%
Shareholder Count 84,093 93,417 90,891 88,966 87,336 102,866 105,330 99,586

Tarsons Products Share Dividend Screener - Share Yield Analysis

Check Tarsons Products dividend history with payout and yield data. View Tarsons Products dividend details including ex-dates and amounts for TARSONS stock.
Period Dividend Per Share Dividend Yield
2026-March ₹0.00 0.00%
2025-March ₹0.00 0.00%
2024-March ₹2.00 0.66%
2023-March ₹0.00 0.00%
2022-March ₹0.00 0.00%
2021-March ₹0.00 0.00%
2020-March ₹0.00 0.00%
2019-March ₹0.00 0.00%
2018-March ₹0.00 0.00%
2017-March ₹0.00 0.00%

Tarsons Products Stock Index Membership

See which indices include Tarsons Products stock. Check TARSONS index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
BSE 1000
BSE INDEX BSE HC
BSE INDEX SMLCAP

Tarsons Products Market Events Screener - Corporate Actions

Get Tarsons Products corporate actions including splits, bonuses, and buybacks. Check Tarsons Products stock events that may affect TARSONS share price.
Announcement Date Record Date Event Type Information Price Impact
2026-05-22 2026-05-22 Quarterly Result Announcement NA 1.28%
2026-02-06 2026-02-06 Quarterly Result Announcement NA 5.73%
2025-11-12 2025-11-12 Quarterly Result Announcement NA -7.25%
2025-09-22 2025-09-22 Annual General Meeting NA -17.14%
2025-08-12 2025-08-12 Quarterly Result Announcement NA 0.51%
2025-05-28 2025-05-28 Quarterly Result Announcement NA 11.62%
2025-02-14 2025-02-14 Quarterly Result Announcement NA -9.49%
2024-11-07 2024-11-07 Quarterly Result Announcement NA 3.04%
2024-09-27 2024-09-27 Annual General Meeting NA -2.81%
2024-09-20 2024-09-20 Dividend ₹ 2.00 /share 11.87%

Tarsons Products Competitors Screener - Peer Comparison

Screen TARSONS competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Poly Medicure 17,190 54.41 1,875 6.61% 326 57.03
Tarsons Products 1,660 104.37 423 3.45% 16 64.95
Laxmi Dental 1,236 42.54 272 12.00% 22 53.38
Q-Line Biotech 1,193 22.24 342 5.93% 56 42.91
Osel Devices 798 26.98 293 56.84% 30 43.84
Vasa Denticity 748 73.60 279 10.97% 10 65.76
Fabtech Technologies 666 17.61 411 22.29% 36 37.60
Hemant Surgical Industries 582 31.44 232 107.34% 19 64.89
Prevest Denpro 459 22.85 72 7.02% 21 47.28
Aprameya Engineering 282 57.17 55 -59.83% 5 42.14

Tarsons Products Company Announcements - News Screener

Screen TARSONS latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
Date Update Actions
2026-07-09 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2026-06-23 Closure of Trading Window -
2026-06-18 Clarification Sought From Tarsons Products Limited -
2026-06-18 Clarification sought from Tarsons Products Ltd -
2026-06-17 Clarification Sought From Tarsons Products Limited -
2026-06-17 Clarification sought from Tarsons Products Ltd -
2026-06-15 Announcement under Regulation 30 (LODR)-Change in Management -
2026-06-06 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation -
2026-06-06 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation -
2026-06-03 Intimation Under Regulation 30 Of SEBI LODR Regulations 2015 Regarding Equity Investment. -
2026-06-01 Announcement under Regulation 30 (LODR)-Earnings Call Transcript -
2026-05-25 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome -
2026-05-23 Announcement under Regulation 30 (LODR)-Investor Presentation -
2026-05-23 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-05-22 Announcement under Regulation 30 (LODR)-Change in Management -
2026-05-22 Audited (Standalone And Consolidated) Financial Results For The Quarter And Financial Year Ended March 31 2026. -
2026-05-22 Board Meeting Outcome for Outcome Of The Board Meeting Held On Friday May 22 2026 -
2026-05-19 Compliances-Reg.24(A)-Annual Secretarial Compliance -
2026-05-18 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation -
2026-05-18 Board Meeting Intimation for Considering And Approving The Audited Standalone And Consolidated Financial Results For The Quarter And Financial Year Ended March 31 2026 -